BioWorld MedTech

Aug. 20, 2014

Financings: HQC closes debut fund at $110M to invest in healthcare sectors

HealthQuest Capital (HQC; Menlo Park, California), a new fund sponsored by Sofinnova Ventures, reported the closing of its debut fund at the hard cap of $110 million and in excess of the initial fund target of $50 million. Read More

Nasal brush test could safely diagnose early prion infection in patients

Medtronic sees profit decline, improvement in sales for 1Q14

Protectionist policy being pursued: China to promote domestic devices among its top hospital facilities

HIT Bits: Firm shows how crucial EMRs are in the big data revolution

Agreements/contracts: Cytori and BARDA continue cell development for thermal burns

Daily M&A: LeMaitre Vascular acquires Xenotis for $7.7 million

Product briefs

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

LINC01116 has prognostic value in lung cancer, study shows

BioWorld Science

Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...

Science in 2025: the best of the rest

BioWorld Science

A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.